Mice treated with doxorubicin had lower expression of tumor HIF-1α and HIF-2α than did controls (Figure 4B), and those treated with doxorubicin plus FO/Se expressed significantly lower levels of HIF-1α and HIF-2α protein than did those treated with doxorubicin alone. The gene discussed is HIF1A; the disease is neoplasm.